Pelin Cinar

955 total citations
35 papers, 658 citations indexed

About

Pelin Cinar is a scholar working on Oncology, Cancer Research and Epidemiology. According to data from OpenAlex, Pelin Cinar has authored 35 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 9 papers in Cancer Research and 6 papers in Epidemiology. Recurrent topics in Pelin Cinar's work include Pancreatic and Hepatic Oncology Research (10 papers), Cancer Genomics and Diagnostics (9 papers) and Neuroendocrine Tumor Research Advances (5 papers). Pelin Cinar is often cited by papers focused on Pancreatic and Hepatic Oncology Research (10 papers), Cancer Genomics and Diagnostics (9 papers) and Neuroendocrine Tumor Research Advances (5 papers). Pelin Cinar collaborates with scholars based in United States, South Africa and France. Pelin Cinar's co-authors include Hoda Anton‐Culver, Jason A. Zell, Frank L. Meyskens, Mehrdad Mobasher, Argyrios Ziogas, Margaret A. Tempero, Hope E. Uronis, Andrew H. Ko, Ignacio Garrido‐Laguna and Daniel A. Laheru and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and CA A Cancer Journal for Clinicians.

In The Last Decade

Pelin Cinar

33 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pelin Cinar United States	13	541	141	136	103	81	35	658
John Broggio United Kingdom	15	373 0.7×	209 1.5×	186 1.4×	102 1.0×	58 0.7×	33	672
Nestory Masalu Tanzania	17	400 0.7×	101 0.7×	214 1.6×	72 0.7×	127 1.6×	55	770
Abdellatif Benider Morocco	16	498 0.9×	130 0.9×	240 1.8×	106 1.0×	167 2.1×	102	906
Nabil Ismaili Morocco	17	404 0.7×	86 0.6×	161 1.2×	125 1.2×	218 2.7×	65	724
René Aloísio da Costa Vieira Brazil	15	392 0.7×	246 1.7×	91 0.7×	68 0.7×	148 1.8×	63	721
Lou Gonsalves United States	16	455 0.8×	83 0.6×	133 1.0×	143 1.4×	154 1.9×	30	781
Mihaela Mates Canada	15	572 1.1×	179 1.3×	69 0.5×	188 1.8×	88 1.1×	50	837
Caroline A. Bray United Kingdom	12	390 0.7×	49 0.3×	122 0.9×	109 1.1×	61 0.8×	18	607
Firas Kreidieh Lebanon	11	241 0.4×	99 0.7×	55 0.4×	68 0.7×	45 0.6×	34	528
J. Daniel Carreon United States	12	453 0.8×	201 1.4×	278 2.0×	70 0.7×	123 1.5×	14	940

Countries citing papers authored by Pelin Cinar

Since Specialization

Citations

This map shows the geographic impact of Pelin Cinar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pelin Cinar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pelin Cinar more than expected).

Fields of papers citing papers by Pelin Cinar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pelin Cinar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pelin Cinar. The network helps show where Pelin Cinar may publish in the future.

Co-authorship network of co-authors of Pelin Cinar

This figure shows the co-authorship network connecting the top 25 collaborators of Pelin Cinar. A scholar is included among the top collaborators of Pelin Cinar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pelin Cinar. Pelin Cinar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Komanduri, Krishna V., Debajyoti Datta, Ayan R. Patel, et al.. (2025). An AI model classifies risks of early relapse post–CAR T-cell therapy in a multicenter real-world population with DLBCL. Blood Advances. 9(22). 5837–5852.

Rugo, Hope, Giuseppe Curigliano, Carlos H. Barrios, et al.. (2024). Abstract PO1-05-09: ASCENT-07: A phase 3, randomized, open-label study of sacituzumab govitecan versus treatment of physician’s choice in patients with HR+/HER2– inoperable, locally advanced, or metastatic breast cancer post-endocrine therapy. Cancer Research. 84(9_Supplement). PO1–5. 6 indexed citations

Fidelman, Nicholas, Chloé E. Atreya, Julia Carnevale, et al.. (2022). Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases. BMC Cancer. 22(1). 1307–1307. 6 indexed citations

Walker, Evan J., Amie Blanco, Julia Carnevale, et al.. (2022). The Additional Diagnostic Benefit of Pancreatic Cancer Molecular Profiling After Germline Testing. Pancreas. 51(4). 302–304. 3 indexed citations

Bocobo, Andrea Grace, Spencer C. Behr, Julia Carnevale, et al.. (2022). Phase II study of pembrolizumab plus capecitabine and bevacizumab in microsatellite stable (MSS) metastatic colorectal cancer (mCRC).. Journal of Clinical Oncology. 40(16_suppl). 3565–3565. 5 indexed citations

Walker, Evan J., Dena Goldberg, Julia Carnevale, et al.. (2021). Implementation of an Embedded In-Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic Adenocarcinoma. The Oncologist. 26(11). e1982–e1991. 23 indexed citations

Cinar, Pelin, Richard J. Bold, Daniela A. Bota, et al.. (2020). Planning for post‐pandemic cancer care delivery: Recovery or opportunity for redesign?. CA A Cancer Journal for Clinicians. 71(1). 34–46. 14 indexed citations

Walker, Evan J., et al.. (2020). Postoperative Exacerbation of Oxaliplatin-induced Neurotoxicity in Gastrointestinal Cancers: A Case Series. Anticancer Research. 40(2). 865–871. 1 indexed citations

Cinar, Pelin, Timothy Kubal, Alison G. Freifeld, et al.. (2020). Safety at the Time of the COVID-19 Pandemic: How to Keep Our Oncology Patients and Healthcare Workers Safe. Journal of the National Comprehensive Cancer Network. 18(5). 504–509. 79 indexed citations

10.

Sohal, Davendra, Erin B. Kennedy, Pelin Cinar, et al.. (2020). Metastatic Pancreatic Cancer: ASCO Guideline Update. Journal of Clinical Oncology. 38(27). 3217–3230. 180 indexed citations

11.

Borno, Hala T., Celia P. Kaplan, Yoon-Ji Kim, et al.. (2019). A step towards equitable clinical trial recruitment: a protocol for the development and preliminary testing of an online prostate cancer health information and clinical trial matching tool. Pilot and Feasibility Studies. 5(1). 123–123. 8 indexed citations

12.

Cinar, Pelin, et al.. (2019). CA 19-9 Response. American Journal of Clinical Oncology. 42(12). 898–902. 20 indexed citations

13.

Mulvey, Claire K., Nitya Raj, Jennifer A. Chan, et al.. (2019). Phase II study of pembrolizumab-based therapy in previously treated extrapulmonary poorly differentiated neuroendocrine carcinomas: Results of Part A (pembrolizumab alone).. Journal of Clinical Oncology. 37(4_suppl). 363–363. 18 indexed citations

14.

Kelley, Robin Kate, Spencer C. Behr, Jimmy J. Hwang, et al.. (2018). Phase 2 trial of pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC): Clinical outcomes and biomarker analyses.. Journal of Clinical Oncology. 36(15_suppl). 4087–4087. 12 indexed citations

15.

Kelley, Robin Kate, Spencer C. Behr, Jimmy J. Hwang, et al.. (2018). Phase II trial of pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC).. Journal of Clinical Oncology. 36(4_suppl). 386–386. 13 indexed citations

16.

Cinar, Pelin & Andrew H. Ko. (2017). Best practices for the treatment of metastatic pancreatic adenocarcinoma: the therapeutic landscape in 2017. Chinese Clinical Oncology. 6(3). 29–29. 2 indexed citations

17.

Bahary, Nathan, Ignacio Garrido‐Laguna, Pelin Cinar, et al.. (2016). Phase 2 trial of the indoleamine 2,3-dioxygenase pathway (IDO) inhibitor indoximod plus gemcitabine/nab-paclitaxel for the treatment of metastatic pancreas cancer: Interim analysis.. Journal of Clinical Oncology. 34(15_suppl). 3020–3020. 30 indexed citations

18.

Cinar, Pelin & Andrew H. Ko. (2014). Evolving Treatment Options for Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma. Journal of the National Comprehensive Cancer Network. 12(2). 167–172. 2 indexed citations

19.

Cinar, Pelin, et al.. (2014). A case series of patients with HER2-overexpressed primary metastatic gastroesophageal adenocarcinoma.. PubMed. 34(12). 7357–60. 8 indexed citations

20.

Cinar, Pelin & Margaret A. Tempero. (2012). Monoclonal Antibodies and Other Targeted Therapies for Pancreatic Cancer. The Cancer Journal. 18(6). 653–664. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact